Selective depletion of myelin-reactive T cells with the anti-OX-40 antibody ameliorates autoimmune encephalomyelitis

Nature Medicine

Volumn 2, Issue 2, 1996, Pages 183-189

  Weinberg, A D ^a,b,f   Bourdette, D N ^a,b   Sullivan, T J ^a   Lemon, M ^a   Wallin, J J ^a   Maziarz, R ^a,b   Davey, M ^a,b   Palida, F ^c   Godfrey, W ^e   Engleman, E ^e   Fulton, R J ^d   Offner, H ^a,b   Vandenbark, A A ^a,b  

^a PORTLAND VA MEDICAL CENTER   (United States)

^b OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

^c BD Technologies   (United States)

^d Inland Laboratory   (United States)

^e STANFORD UNIVERSITY   (United States)

^f PROVIDENCE PORTLAND MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBODY; IMMUNOTOXIN; MYELIN; OX40 PROTEIN; RICIN A; UNCLASSIFIED DRUG;

ALLERGIC ENCEPHALOMYELITIS; ANIMAL EXPERIMENT; ARTICLE; AUTOIMMUNITY; CASE REPORT; GRAFT VERSUS HOST REACTION; HUMAN; NONHUMAN; PRIORITY JOURNAL; RAT; RHEUMATOID ARTHRITIS; T LYMPHOCYTE;

ANIMALS; ANTIGENS, CD27; ARTHRITIS, RHEUMATOID; CD4-POSITIVE T-LYMPHOCYTES; CELL SEPARATION; ENCEPHALOMYELITIS, AUTOIMMUNE, EXPERIMENTAL; HUMANS; IMMUNOTOXINS; MYELIN BASIC PROTEINS; RATS; RATS, INBRED LEW; RECEPTORS, OX40; RECEPTORS, TUMOR NECROSIS FACTOR; RICIN; T-LYMPHOCYTE SUBSETS;

EID: 13344283418     PISSN: 10788956     EISSN: None     Source Type: Journal    
DOI: 10.1038/nm0296-183     Document Type: Article

References (26)

1. Swanborg, R.H. Autoimmune effector cells. V. A monoclonal antibody specific for rat helper T lymphocytes inhibits adoptive transfer of auto-immune encephalomyelitis. J. Immunol. 130, 1503-1505 (1983).
2. Cush, J.J. & Lipsky, P.E. Phenotypic analysis of synovial tissue and peripheral blood lymphocytes isolated from patients with rheumatoid arthritis. Arthritis Rheum. 31, 1230-1238 (1988).
3. Caspi, R.R. et al. A new model of autoimmune disease: Experimental autoimmune uveoretinitis induced in mice with two different retinal antigens. J. Immunol. 140, 1490-1495 (1988).
4. Cobbold, S.P., Nash, J.A., Prospero, T.D. & Waldmann, H. Therapy with monoclonal antibodies by elimination of T-cell subsets in vivo. Nature 312, 548-551 (1988).
5. Steinman, L. Autoimmune disease. Sci. Am. 269, 106-114 (1993).
6. Weinberg, A.D. et al. Target organ specific upregulation of the MRC OX-40 marker and selective production of Th1 lymphokine mRNA by encephalitogenic T helper cells isolated from the spinal cord of rats with experimental autoimmune encephalomyelitis. J. Immunol. 152, 4712-4721 (1994).
7. Weinberg, A.D. et al. TGF-β enhances the in vivo effector function and memory phenotype of Ag-specific T helper cells in EAE. J. Immunol. 148, 2109-2117 (1992).
8. Weiner, H.L. et al. Double-blind pilot trial of oral tolerization with myelin antigens in MS. Science 259, 1321-1324 (1993).
9. Vandenbark, A.A., Hashim, G. & Offner, H. Immunization with a synthetic T-cell receptor V-region peptide protects against experimental autoimmune encephalomyelitis. Nature 341, 541-544 (1989).
10. Howell, M.D. et al. Vaccination against experimental allergic encephalomyelitis with T cell receptor peptides. Science 246, 668-670 (1989).
11. + T cells within the spinal cord of Lewis rats with autoimmune encephalomyelitis. J. Neurosci. Res. (in the press).
12. Paterson, P.Y. Multiple sclerosis: An immunologic reassessment. J. Chron. Dis. 26, 119-125 (1981).
13. Oksenberg, J.R. et al. Selection of T-cell receptor V-D-J gene rearrangements with specificity for a MBP peptide in brain lesions of MS. Nature 362, 68-70 (1993).
14. Yednock, T.A. et al. Prevention of experimental autoimmune encephalomyelitis by antibodies against α4/β1 integrin. Nature 356, 63 (1992).
15. Jameson, B.A., McDonnel, J.M., Marini, J.C. & Korngold, R. A rationally designed CD4 analogue Inhibits experimental allergic encephalomyelitis. Nature 368, 744-746 (1994).
16. Vandenbark, A.A., Gill, T. & Offner, H. A myelin basic protein specific T lymphocyte line which mediates EAE. J. Immunol. 135, 223-228 (1985).
17. Matsumoto, Y. & Fujiwara, M. Adoptively transferred EAE in chimeric rats: Identification of transferred cells in the lesions of the CNS. Immunology 65, 23-29 (1988).
18. Ortiz-Ortiz, L., Nakamura, R.M. & Weigle, W.O. T cell requirement for EAE induction in the rat. J. Immunol. 117, 576-578 (1976).
19. Bourdette, D.N. et al. Myelin basic protein specific T cells in the CNS and lymph nodes of rats with EAE are different. J. Neurosci. Res. 30, 308-315 (1991).
20. Hintzen, R.Q., de Jong, R., Lens, S.M.A. & van Lier, R.A.W. CD27: Marker and mediator of T-cell activation? Immunol. Today 15, 307-311 (1994).
21. 1 detected only on CD4 positive T blasts. Mol. Immunol. 24, 1281-1290 (1987).
22. Latza, U. et al. The human OX40 homologue: cDNA structure, expression and chromosomal assignment of the ACT35 antigen. Eur. J. Immunol. 24, 677-683 (1994).
23. Baum, P.R. et al. Molecular characterization of murine and human OX-40/OX-40 ligand systems: Identification of a human OX-40 ligand as the HTLV-1-regulated protein gp34. EMBO J. 13, 3992-4001 (1994).
24. +T cells with homology to tumor necrosis factor. J. Exp. Med. 180, 757-762 (1994).
25. Kruisbeek, A.M. Isolation and fractionation of mononuclear cell populations, in Current Protocols in Immunology (eds Coligan, J.E., Kruisbeek, A.M., Margulies, D.H., Shevach, E.M. & Strober, W.) 3.1.3-3.1.5 (Greene Publishing and Wiley-Interscience, New York, 1992).
26. Press, O.W., Vitteta, E.S., Farr, A.G., Hansen, J.A. & Martin, P.J. Evaluation of ricin A-chain immunotoxins directed against human T cells. Cell. Immunol. 102, 10-20 (1986).